Search

  • Sort by

  • Category

  • Post Type

  • Reset

Former FDA Associate Commissioner Warns of the “Massive Safety Risks of Importation”

March 3, 2020
Posted in ,

This editorial by Peter J. Pitts was published in The Times Weekly on March 3, 2020. Mr. Pitts is president of the Center for Medicine in the Public Interest and a former FDA associate commissioner. Keep Canadian drugs out of U.S. medicine cabinets The Trump administration recently proposed two rules that would allow states, pharmacies, and drug wholesalers to import…

Read More

49 States Have Reported Deadly Counterfeit Pills Made with Fentanyl, January 2020

March 3, 2020
Posted in ,
Read More

House Resolution demands open access to WHOIS Results

March 3, 2020
Posted in ,

WHOIS data is searchable registrar information available for all websites on the Internet. It has long been used to trace criminal websites that host counterfeit and illicit drug sales, human trafficking, child pornography, and illicit and copyrighted content, as well as the websites of spammers, denial-of-services and phishing attackers, and other fraudsters.

Read More
photo of Josh Holton

Tennessean’s Life Cut Short After Following Journalist’s Advice

March 2, 2020
Posted in ,

20-year-old Joshua Holton died of fentanyl poisoning in Tennessee after he took Xanax he’d bought online. He’d seen a TED talk online that suggested that users reviews were a reliable way to judge the quality of the drugs they were selling—but they weren’t.

Read More
photo of Ujjal Dosanjh

Canadian drug importation is “an economic fantasy,” former Canadian health minister says.

March 2, 2020
Posted in ,

In this editorial in The Globe and Mail, Ujjal Dosanjh, formerly a federal minister of health and a premier of British Columbia, explains that drug manufacturers have no incentive to sell Canadian provinces more medicine to fill the needs of U.S. residents. Importation will lead to drug shortages in Canada and counterfeit drug trafficking to the U.S.

Read More

FDA Alert: Med Man Expands Voluntary Nationwide Recall of Up2 and Bow & Arrow Due to Presence of Undeclared Sildenafil

February 24, 2020
Posted in ,

This is a reprint of an FDA Alert. When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or the company. Company Announcement Date: February 24, 2020 FDA Publish Date: February 24, 2020 Product Type: Dietary Supplements Reason for Announcement: Product is…

Read More

FDA Worked With Indian Government To Seize 500 Counterfeit Drug Shipments in January

February 21, 2020
Posted in , ,

The U.S. Food and Drug Administration (FDA) has just announced a successful joint operation with the Government of India targeting counterfeit prescription drugs, counterfeit over-the-counter medications, fake medical devices, and misbranded dietary supplements containing harmful ingredients. 

Read More
graph comparing the population of Canada to the US

Canadian Importation Does Not Work

February 21, 2020
Posted in ,

The number of U.S. residents in states that are considering importing drugs from Canada is almost four times Canada’s own population. Canadian drug importation is not the structural solution we need.

Read More
front side of the bookmark

“5 Ways” consumer bookmark

February 19, 2020
Posted in

Download our “5 Ways” Consumer Bookmark for a quick reference about how to protect yourself from counterfeit medicine.  

Read More

Policy Resolution, January 8, 2020

February 18, 2020
Posted in

The following policy resolution was passed unanimously at the Jan. 8, 2020 board meeting in Washington DC. The governing board of the Partnership for Safe Medicines votes today to reiterate that the Partnership is organized to focus entirely of the safety of medicine as it travels through the supply chain, as we have since our founding sixteen years ago. To…

Read More